Two senators wrote to the FDA Friday about the Hims Super Bowl ad, which they said misleads patients about compounded weight ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.

No matter what the Trump administration does, international telehealth services, websites that sell pills and community ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

A San Francisco online health company that recently faced local backlash over its donation to President Donald Trump’s inauguration is now in hot water over a Super Bowl ad. Hims & Hers, a telehealth ...

Hims & Hers, a San Francisco-headquartered telehealth company, ran its controversial Super Bowl commercial despite multiple ...

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.